Naringenin have been reported to reduce the expression of signalling molecules such as IL-6, IL-8, inducible nitric oxide synthase (iNOS), and nuclear erythroid-related factor (Nrf2) associated with heart injury [57]. This evidence concerns the gene CXCL8 and injury.